Advertisement
U.S. Markets closed

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.8500-0.0100 (-0.54%)
At close: 04:00PM EDT
1.8500 0.00 (0.00%)
After hours: 07:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.8600
Open1.9000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.8400 - 1.9255
52 Week Range0.7650 - 2.3400
Volume261,771
Avg. Volume463,117
Market Cap254.54M
Beta (5Y Monthly)0.73
PE Ratio (TTM)N/A
EPS (TTM)-0.3500
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.57
  • GlobeNewswire

    Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting

    BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the acceptance of an abstract for poster presentation at the upcoming 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting, being held from November 8–10, 2024 at the George R. Brown Convention Center in Houston, TX. Presentation Details: Post

  • GlobeNewswire

    Compass Therapeutics to Participate in Upcoming Investor Events

    BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2024. Details are as follows: H.C. Wainwright 26th Annual Global Investment Conference Location: New York, NY Date: Monday, September 9, 2024 Time: 11:00am